| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Jan 25 | ANTX AN2 Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.341 | 9,663 | 12.96 k | 116,672 |
| 4 Nov 24 | ANTX AN2 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 31,500 | 0.00 | 126,335 |
| 4 Nov 24 | ANTX AN2 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 63,000 | 68.04 k | 63,000 |
| 10 Jul 24 | ANTX AN2 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 60,000 | 0.00 | 94,833 |
| 15 Mar 24 | ANTX AN2 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 32,447 |
| 15 Mar 24 | ANTX AN2 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3 | 60,000 | 180.00 k | 60,000 |
| 15 Mar 24 | ANTX AN2 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 32,447 |
